Atlas Trials

Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma

Clinical trial NCT00547534 · COMPLETED

Trial details

NCT number
NCT00547534
Sponsor
University of Rochester
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's Lymphoma
Start date
2007-10-01
Primary completion
2009-06-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.